You can buy Anlotib at the lowest price in the online pharmacy Nextgen.ooo . Anlotinib is a novel, orally administered tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptors (PDGFR), and c-kit. Compared with placebo, it improved both progression-free survival and overall survival in a phase III study in patients with advanced non-small cell lung cancer (NSCLC), despite cancer progression after two lines of previous treatment. Recently, the China Food and Drug Administration (CFDA) approved single-agent anlotinib as a third-line treatment for patients with advanced NSCLC.
 
In addition, a randomized phase IIB study showed that anlotinib significantly prolonged median progression-free survival in patients with advanced soft tissue sarcoma. Anlotinib has also shown promising efficacy in patients with advanced medullary thyroid carcinoma and metastatic renal cell carcinoma.
 
The tolerability profile of anlotinib is similar to that of other tyrosine kinase inhibitors that target VEGFR and other tyrosine kinase-mediated pathways; however, anlotinib has a significantly lower rate of grade 3 or higher adverse events compared with sunitinib.